222 results on '"Cai, Jia-Bin"'
Search Results
2. Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy
3. The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion
4. Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis
5. Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma
6. WDR4/TRIM28 is a novel molecular target linked to lenvatinib resistance that helps retain the stem characteristics in hepatocellular carcinomas
7. Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy
8. Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis
9. KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma
10. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
11. Perioperative complication incidence and risk factors for retroperitoneal neuroblastoma in children: analysis of 571 patients
12. Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?
13. Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
14. TGM3 promotes epithelial–mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection
15. A prospective study of the effect of terlipressin on portal vein pressure and clinical outcomes after hepatectomy: A pilot study
16. Dexamethasone for postoperative hyperbilirubinemia in patients after liver resection: An open-label, randomized controlled trial
17. Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma.
18. Corrigendum to: “PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma” [J Hepatol 77 (2022) 163-176]
19. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
20. Circular RNA circTRIM33–12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression
21. Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma
22. The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion
23. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma
24. Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis
25. Clinical experience in the treatment of children who swallowed multiple magnetic foreign bodies: A report of five cases
26. Neoadjuvant transcatheter arterial chemoembolization and systemic chemotherapy for the treatment of undifferentiated embryonal sarcoma of the liver in children
27. NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells
28. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma
29. Additional file 1 of KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma
30. Additional file 2 of KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma
31. Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma
32. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications
33. Mitogen-Activated Protein Kinase Kinase Kinase 4 Deficiency in Intrahepatic Cholangiocarcinoma Leads to Invasive Growth and Epithelial-Mesenchymal Transition
34. TM2D1 contributes the epithelial-mesenchymal transition of hepatocellular carcinoma via modulating AKT/β-catenin axis
35. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma
36. CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expression
37. Ubiquitin-Specific Protease 7 Accelerates p14ARF Degradation by Deubiquitinating Thyroid Hormone Receptor-Interacting Protein 12 and Promotes Hepatocellular Carcinoma Progression
38. Additional file 2 of Amplification of spatially isolated adenosine pathway by tumor���macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
39. Additional file 1 of Amplification of spatially isolated adenosine pathway by tumor���macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
40. Expression and clinical significance of heparanase in neuroblastoma
41. Enhanced Expression of Resistin-like Molecule Beta in Human Colon Cancer and Its Clinical Significance
42. Expression and clinical significance of stem cell marker CD133 in human neuroblastoma
43. Additional file 2 of Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
44. Additional file 1 of Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
45. Additional file 3 of Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
46. CircRNA UBAP2 Serves as a Sponge of miR-1294 to Increase Tumorigenesis in Hepatocellular Carcinoma through Regulating c-Myc Expression
47. Paraplegia after transcatheter artery chemoembolization in a child with clear cell sarcoma of the kidney: A case report
48. Unusual presentation of bladder neuroblastoma in a child: A case report
49. Natural jasmonates of different structures suppress the growth of human neuroblastoma cell line SH-SY5Y and its mechanisms
50. Additional file 5: of Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.